盟科药业-U涨停 5只科创板股涨超10%

Group 1 - The core point of the news is that Mengke Pharmaceutical-U experienced a significant increase in stock price, reaching a limit up of 20.02% during trading on September 23, with a trading volume of 635 million yuan and a turnover rate of 13.05% [1] - Among the stocks listed on the Sci-Tech Innovation Board, 57 stocks were reported to be rising, with 5 stocks showing an increase of over 10%, including Mengke Pharmaceutical-U, Haibosi Chuang, and Jingzhida [1] - Conversely, 528 stocks were reported to be declining, with notable decreases in ST Sike Rui, De Ke Li, and Kai Pu Yun, which fell by 13.49%, 9.80%, and 8.98% respectively [1] Group 2 - In terms of capital flow, Mengke Pharmaceutical-U saw a net outflow of 2.4013 million yuan from main funds on the previous trading day, but a net inflow of 34.505 million yuan over the past five days [2] - The latest margin trading data as of September 22 shows a total margin balance of 85.0489 million yuan, with a decrease of 0.74% from the previous trading day [2] - Over the past ten days, the total margin balance increased by 0.40%, with the financing balance also growing by 0.40% [2] - In terms of institutional ratings, the stock received a buy rating from one institution in the past month, with a report from Guangda Securities on August 27 recommending a buy [2]